Galapagos NV (GXEA) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.026x

Based on the latest financial reports, Galapagos NV (GXEA) has a cash flow conversion efficiency ratio of -0.026x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-62.61 Million ≈ $-73.19 Million USD) by net assets (€2.45 Billion ≈ $2.86 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Galapagos NV - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Galapagos NV's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read GXEA liabilities breakdown for a breakdown of total debt and financial obligations.

Galapagos NV Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Galapagos NV ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Tyra Biosciences Inc NASDAQ:TYRA	-0.091x
Bikaji Foods International Limited NSE:BIKAJI	0.020x
Grupo Gigante S. A. B. de C. V MX:GIGANTE	0.046x
Ora Banda Mining Ltd AU:OBM	0.472x
Harmony Biosciences Holdings NASDAQ:HRMY	0.130x
Malaysian Pacific Industries KLSE:3867	0.070x
LTC Properties Inc NYSE:LTC	0.037x
Akr Corporindo Tbk JK:AKRA	0.035x

Annual Cash Flow Conversion Efficiency for Galapagos NV (2016–2024)

The table below shows the annual cash flow conversion efficiency of Galapagos NV from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see Galapagos NV (GXEA) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€2.90 Billion ≈ $3.39 Billion	€-320.03 Million ≈ $-374.14 Million	-0.110x	+40.49%
2023-12-31	€2.80 Billion ≈ $3.27 Billion	€-518.97 Million ≈ $-606.73 Million	-0.186x	+6.32%
2022-12-31	€2.53 Billion ≈ $2.95 Billion	€-500.54 Million ≈ $-585.19 Million	-0.198x	-3.96%
2021-12-31	€2.64 Billion ≈ $3.09 Billion	€-503.83 Million ≈ $-589.03 Million	-0.191x	-19.10%
2020-12-31	€2.67 Billion ≈ $3.12 Billion	€-427.34 Million ≈ $-499.60 Million	-0.160x	-114.34%
2019-12-31	€2.88 Billion ≈ $3.36 Billion	€3.21 Billion ≈ $3.75 Billion	1.116x	+1050.99%
2018-12-31	€1.21 Billion ≈ $1.42 Billion	€-142.47 Million ≈ $-166.56 Million	-0.117x	+19.24%
2017-12-31	€1.01 Billion ≈ $1.18 Billion	€-147.03 Million ≈ $-171.89 Million	-0.145x	-146.04%
2016-12-31	€758.70 Million ≈ $887.00 Million	€239.40 Million ≈ $279.89 Million	0.316x	--

About Galapagos NV

F:GXEA Germany Biotechnology

Market Cap

$1.83 Billion

€1.57 Billion EUR

Market Cap Rank

#6600 Global

#963 in Germany

Share Price

€23.80

Change (1 day)

-1.65%

52-Week Range

€22.40 - €31.40

All Time High

€246.00